nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiagabine—CYP3A4—Rifampicin—leprosy	0.169	0.548	CbGbCtD
Tiagabine—CYP3A4—Dapsone—leprosy	0.14	0.452	CbGbCtD
Tiagabine—Benign neoplasm of skin—Thalidomide—leprosy	0.0338	0.049	CcSEcCtD
Tiagabine—Suicide attempt—Dapsone—leprosy	0.0158	0.0228	CcSEcCtD
Tiagabine—Circumoral paresthesia—Thalidomide—leprosy	0.014	0.0203	CcSEcCtD
Tiagabine—Hyporeflexia—Thalidomide—leprosy	0.0101	0.0146	CcSEcCtD
Tiagabine—Hernia—Thalidomide—leprosy	0.00976	0.0141	CcSEcCtD
Tiagabine—Paraesthesia oral—Thalidomide—leprosy	0.00976	0.0141	CcSEcCtD
Tiagabine—Neck stiffness—Thalidomide—leprosy	0.00962	0.0139	CcSEcCtD
Tiagabine—Cerebral ischaemia—Thalidomide—leprosy	0.00947	0.0137	CcSEcCtD
Tiagabine—Peripheral vascular disorder—Thalidomide—leprosy	0.00934	0.0135	CcSEcCtD
Tiagabine—Nuchal rigidity—Thalidomide—leprosy	0.00883	0.0128	CcSEcCtD
Tiagabine—Hostility—Thalidomide—leprosy	0.00827	0.012	CcSEcCtD
Tiagabine—Vesiculobullous rash—Thalidomide—leprosy	0.00817	0.0118	CcSEcCtD
Tiagabine—Suicide attempt—Thalidomide—leprosy	0.00807	0.0117	CcSEcCtD
Tiagabine—Psoriasis—Thalidomide—leprosy	0.00728	0.0105	CcSEcCtD
Tiagabine—Myasthenia—Thalidomide—leprosy	0.00728	0.0105	CcSEcCtD
Tiagabine—Hypothyroidism—Thalidomide—leprosy	0.00713	0.0103	CcSEcCtD
Tiagabine—Hepatomegaly—Thalidomide—leprosy	0.00647	0.00936	CcSEcCtD
Tiagabine—Nystagmus—Thalidomide—leprosy	0.00641	0.00928	CcSEcCtD
Tiagabine—Metrorrhagia—Thalidomide—leprosy	0.00641	0.00928	CcSEcCtD
Tiagabine—Hyperlipidaemia—Thalidomide—leprosy	0.00635	0.00919	CcSEcCtD
Tiagabine—Psychotic disorder—Dapsone—leprosy	0.00634	0.00918	CcSEcCtD
Tiagabine—Stupor—Thalidomide—leprosy	0.00613	0.00888	CcSEcCtD
Tiagabine—Neuritis—Thalidomide—leprosy	0.00613	0.00888	CcSEcCtD
Tiagabine—Amblyopia—Thalidomide—leprosy	0.00593	0.00858	CcSEcCtD
Tiagabine—Skin ulcer—Thalidomide—leprosy	0.00588	0.00851	CcSEcCtD
Tiagabine—Rash pustular—Thalidomide—leprosy	0.00574	0.00831	CcSEcCtD
Tiagabine—Muscular weakness—Dapsone—leprosy	0.00573	0.00829	CcSEcCtD
Tiagabine—Influenza—Dapsone—leprosy	0.00561	0.00812	CcSEcCtD
Tiagabine—Petechiae—Thalidomide—leprosy	0.00557	0.00805	CcSEcCtD
Tiagabine—Apnoea—Thalidomide—leprosy	0.0054	0.00782	CcSEcCtD
Tiagabine—Vasodilation—Thalidomide—leprosy	0.00521	0.00754	CcSEcCtD
Tiagabine—Amenorrhoea—Thalidomide—leprosy	0.00521	0.00754	CcSEcCtD
Tiagabine—Vasodilation procedure—Thalidomide—leprosy	0.00521	0.00754	CcSEcCtD
Tiagabine—Accidental injury—Thalidomide—leprosy	0.00517	0.00749	CcSEcCtD
Tiagabine—Photosensitivity reaction—Dapsone—leprosy	0.00512	0.00741	CcSEcCtD
Tiagabine—Musculoskeletal stiffness—Thalidomide—leprosy	0.0051	0.00739	CcSEcCtD
Tiagabine—Cellulitis—Thalidomide—leprosy	0.00504	0.00729	CcSEcCtD
Tiagabine—Arthropathy—Thalidomide—leprosy	0.00504	0.00729	CcSEcCtD
Tiagabine—Thinking abnormal—Thalidomide—leprosy	0.005	0.00724	CcSEcCtD
Tiagabine—Herpes simplex—Thalidomide—leprosy	0.00497	0.00719	CcSEcCtD
Tiagabine—Neuropathy peripheral—Dapsone—leprosy	0.0049	0.0071	CcSEcCtD
Tiagabine—Dyskinesia—Thalidomide—leprosy	0.00487	0.00705	CcSEcCtD
Tiagabine—Hypercholesterolaemia—Thalidomide—leprosy	0.00484	0.00701	CcSEcCtD
Tiagabine—Sinusitis—Dapsone—leprosy	0.00469	0.00679	CcSEcCtD
Tiagabine—Gait disturbance—Thalidomide—leprosy	0.00469	0.00679	CcSEcCtD
Tiagabine—Coordination abnormal—Thalidomide—leprosy	0.00466	0.00675	CcSEcCtD
Tiagabine—Neck pain—Thalidomide—leprosy	0.00463	0.00671	CcSEcCtD
Tiagabine—Eructation—Thalidomide—leprosy	0.0045	0.00651	CcSEcCtD
Tiagabine—Pharyngitis—Dapsone—leprosy	0.00446	0.00645	CcSEcCtD
Tiagabine—Depressed level of consciousness—Thalidomide—leprosy	0.00442	0.0064	CcSEcCtD
Tiagabine—Cramps of lower extremities—Thalidomide—leprosy	0.00421	0.00609	CcSEcCtD
Tiagabine—Tinnitus—Dapsone—leprosy	0.00419	0.00606	CcSEcCtD
Tiagabine—Oesophagitis—Thalidomide—leprosy	0.00418	0.00606	CcSEcCtD
Tiagabine—Rash maculo-papular—Thalidomide—leprosy	0.00416	0.00602	CcSEcCtD
Tiagabine—Lightheadedness—Thalidomide—leprosy	0.0041	0.00593	CcSEcCtD
Tiagabine—Hypertonia—Thalidomide—leprosy	0.00401	0.00581	CcSEcCtD
Tiagabine—Hyperkinesia—Thalidomide—leprosy	0.00399	0.00578	CcSEcCtD
Tiagabine—Sepsis—Thalidomide—leprosy	0.00397	0.00575	CcSEcCtD
Tiagabine—Mental disability—Thalidomide—leprosy	0.00397	0.00575	CcSEcCtD
Tiagabine—Euphoric mood—Thalidomide—leprosy	0.00393	0.00569	CcSEcCtD
Tiagabine—Lymphadenopathy—Thalidomide—leprosy	0.0039	0.00564	CcSEcCtD
Tiagabine—Thrombophlebitis—Thalidomide—leprosy	0.00384	0.00556	CcSEcCtD
Tiagabine—Gastroenteritis—Thalidomide—leprosy	0.00375	0.00543	CcSEcCtD
Tiagabine—Deafness—Thalidomide—leprosy	0.00372	0.00538	CcSEcCtD
Tiagabine—Eczema—Thalidomide—leprosy	0.0037	0.00535	CcSEcCtD
Tiagabine—Eye pain—Thalidomide—leprosy	0.00368	0.00533	CcSEcCtD
Tiagabine—Injury—Thalidomide—leprosy	0.00362	0.00523	CcSEcCtD
Tiagabine—Libido decreased—Thalidomide—leprosy	0.00358	0.00519	CcSEcCtD
Tiagabine—Increased appetite—Thalidomide—leprosy	0.00354	0.00512	CcSEcCtD
Tiagabine—Dermatitis exfoliative—Thalidomide—leprosy	0.00352	0.0051	CcSEcCtD
Tiagabine—Vertigo—Dapsone—leprosy	0.00351	0.00508	CcSEcCtD
Tiagabine—Dermatitis bullous—Thalidomide—leprosy	0.00348	0.00503	CcSEcCtD
Tiagabine—Arthritis—Thalidomide—leprosy	0.00342	0.00495	CcSEcCtD
Tiagabine—Cough—Dapsone—leprosy	0.00341	0.00494	CcSEcCtD
Tiagabine—Hypoglycaemia—Thalidomide—leprosy	0.00341	0.00493	CcSEcCtD
Tiagabine—Hyponatraemia—Thalidomide—leprosy	0.00334	0.00483	CcSEcCtD
Tiagabine—Diplopia—Thalidomide—leprosy	0.00332	0.00481	CcSEcCtD
Tiagabine—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.00332	0.00481	CcSEcCtD
Tiagabine—Osteoarthritis—Thalidomide—leprosy	0.00332	0.00481	CcSEcCtD
Tiagabine—Disturbance in sexual arousal—Thalidomide—leprosy	0.0033	0.00477	CcSEcCtD
Tiagabine—Affect lability—Thalidomide—leprosy	0.00327	0.00473	CcSEcCtD
Tiagabine—Migraine—Thalidomide—leprosy	0.00327	0.00473	CcSEcCtD
Tiagabine—Psychotic disorder—Thalidomide—leprosy	0.00325	0.0047	CcSEcCtD
Tiagabine—Face oedema—Thalidomide—leprosy	0.00321	0.00464	CcSEcCtD
Tiagabine—Mood swings—Thalidomide—leprosy	0.00315	0.00456	CcSEcCtD
Tiagabine—Ataxia—Thalidomide—leprosy	0.00313	0.00452	CcSEcCtD
Tiagabine—Tachycardia—Dapsone—leprosy	0.00311	0.00451	CcSEcCtD
Tiagabine—Dehydration—Thalidomide—leprosy	0.00309	0.00447	CcSEcCtD
Tiagabine—Liver function test abnormal—Thalidomide—leprosy	0.00307	0.00444	CcSEcCtD
Tiagabine—Dry skin—Thalidomide—leprosy	0.00305	0.00441	CcSEcCtD
Tiagabine—Orthostatic hypotension—Thalidomide—leprosy	0.00304	0.00439	CcSEcCtD
Tiagabine—Hypokalaemia—Thalidomide—leprosy	0.00302	0.00438	CcSEcCtD
Tiagabine—Muscular weakness—Thalidomide—leprosy	0.00293	0.00424	CcSEcCtD
Tiagabine—Insomnia—Dapsone—leprosy	0.00289	0.00418	CcSEcCtD
Tiagabine—Influenza—Thalidomide—leprosy	0.00287	0.00416	CcSEcCtD
Tiagabine—Dysphagia—Thalidomide—leprosy	0.00287	0.00416	CcSEcCtD
Tiagabine—Angina pectoris—Thalidomide—leprosy	0.0028	0.00405	CcSEcCtD
Tiagabine—Bronchitis—Thalidomide—leprosy	0.00276	0.004	CcSEcCtD
Tiagabine—Pollakiuria—Thalidomide—leprosy	0.00265	0.00384	CcSEcCtD
Tiagabine—Erectile dysfunction—Thalidomide—leprosy	0.00265	0.00383	CcSEcCtD
Tiagabine—Photosensitivity reaction—Thalidomide—leprosy	0.00262	0.00379	CcSEcCtD
Tiagabine—Weight increased—Thalidomide—leprosy	0.00261	0.00378	CcSEcCtD
Tiagabine—Gastrointestinal pain—Dapsone—leprosy	0.00261	0.00378	CcSEcCtD
Tiagabine—Weight decreased—Thalidomide—leprosy	0.0026	0.00376	CcSEcCtD
Tiagabine—Hyperglycaemia—Thalidomide—leprosy	0.00259	0.00375	CcSEcCtD
Tiagabine—Pneumonia—Thalidomide—leprosy	0.00258	0.00373	CcSEcCtD
Tiagabine—Depression—Thalidomide—leprosy	0.00255	0.0037	CcSEcCtD
Tiagabine—Acute coronary syndrome—Thalidomide—leprosy	0.00252	0.00365	CcSEcCtD
Tiagabine—Body temperature increased—Dapsone—leprosy	0.00252	0.00365	CcSEcCtD
Tiagabine—Abdominal pain—Dapsone—leprosy	0.00252	0.00365	CcSEcCtD
Tiagabine—Renal failure—Thalidomide—leprosy	0.00252	0.00364	CcSEcCtD
Tiagabine—Neuropathy peripheral—Thalidomide—leprosy	0.00251	0.00363	CcSEcCtD
Tiagabine—Myocardial infarction—Thalidomide—leprosy	0.00251	0.00363	CcSEcCtD
Tiagabine—Stomatitis—Thalidomide—leprosy	0.0025	0.00361	CcSEcCtD
Tiagabine—Conjunctivitis—Thalidomide—leprosy	0.00249	0.0036	CcSEcCtD
Tiagabine—Sweating—Thalidomide—leprosy	0.00246	0.00355	CcSEcCtD
Tiagabine—Haematuria—Thalidomide—leprosy	0.00244	0.00353	CcSEcCtD
Tiagabine—Epistaxis—Thalidomide—leprosy	0.00242	0.0035	CcSEcCtD
Tiagabine—Sinusitis—Thalidomide—leprosy	0.0024	0.00348	CcSEcCtD
Tiagabine—Rhinitis—Thalidomide—leprosy	0.00231	0.00334	CcSEcCtD
Tiagabine—Hypoaesthesia—Thalidomide—leprosy	0.00229	0.00331	CcSEcCtD
Tiagabine—Pharyngitis—Thalidomide—leprosy	0.00228	0.0033	CcSEcCtD
Tiagabine—Oedema peripheral—Thalidomide—leprosy	0.00227	0.00328	CcSEcCtD
Tiagabine—Visual impairment—Thalidomide—leprosy	0.00222	0.00321	CcSEcCtD
Tiagabine—Tinnitus—Thalidomide—leprosy	0.00214	0.0031	CcSEcCtD
Tiagabine—Chills—Thalidomide—leprosy	0.00206	0.00299	CcSEcCtD
Tiagabine—Alopecia—Thalidomide—leprosy	0.00203	0.00294	CcSEcCtD
Tiagabine—Vomiting—Dapsone—leprosy	0.00203	0.00294	CcSEcCtD
Tiagabine—Headache—Dapsone—leprosy	0.002	0.00289	CcSEcCtD
Tiagabine—Flatulence—Thalidomide—leprosy	0.00197	0.00285	CcSEcCtD
Tiagabine—Tension—Thalidomide—leprosy	0.00196	0.00284	CcSEcCtD
Tiagabine—Dysgeusia—Thalidomide—leprosy	0.00196	0.00284	CcSEcCtD
Tiagabine—Nervousness—Thalidomide—leprosy	0.00194	0.00281	CcSEcCtD
Tiagabine—Back pain—Thalidomide—leprosy	0.00194	0.0028	CcSEcCtD
Tiagabine—Muscle spasms—Thalidomide—leprosy	0.00192	0.00279	CcSEcCtD
Tiagabine—Nausea—Dapsone—leprosy	0.0019	0.00274	CcSEcCtD
Tiagabine—Tremor—Thalidomide—leprosy	0.00188	0.00271	CcSEcCtD
Tiagabine—Ill-defined disorder—Thalidomide—leprosy	0.00186	0.00269	CcSEcCtD
Tiagabine—Anaemia—Thalidomide—leprosy	0.00185	0.00268	CcSEcCtD
Tiagabine—Agitation—Thalidomide—leprosy	0.00184	0.00266	CcSEcCtD
Tiagabine—Malaise—Thalidomide—leprosy	0.0018	0.00261	CcSEcCtD
Tiagabine—Vertigo—Thalidomide—leprosy	0.0018	0.0026	CcSEcCtD
Tiagabine—Syncope—Thalidomide—leprosy	0.00179	0.0026	CcSEcCtD
Tiagabine—Leukopenia—Thalidomide—leprosy	0.00179	0.00259	CcSEcCtD
Tiagabine—Palpitations—Thalidomide—leprosy	0.00177	0.00256	CcSEcCtD
Tiagabine—Loss of consciousness—Thalidomide—leprosy	0.00176	0.00255	CcSEcCtD
Tiagabine—Cough—Thalidomide—leprosy	0.00175	0.00253	CcSEcCtD
Tiagabine—Hypertension—Thalidomide—leprosy	0.00173	0.0025	CcSEcCtD
Tiagabine—Chest pain—Thalidomide—leprosy	0.0017	0.00247	CcSEcCtD
Tiagabine—Arthralgia—Thalidomide—leprosy	0.0017	0.00247	CcSEcCtD
Tiagabine—Myalgia—Thalidomide—leprosy	0.0017	0.00247	CcSEcCtD
Tiagabine—Anxiety—Thalidomide—leprosy	0.0017	0.00246	CcSEcCtD
Tiagabine—Discomfort—Thalidomide—leprosy	0.00168	0.00244	CcSEcCtD
Tiagabine—Dry mouth—Thalidomide—leprosy	0.00167	0.00241	CcSEcCtD
Tiagabine—Confusional state—Thalidomide—leprosy	0.00165	0.00238	CcSEcCtD
Tiagabine—Oedema—Thalidomide—leprosy	0.00163	0.00236	CcSEcCtD
Tiagabine—Infection—Thalidomide—leprosy	0.00162	0.00235	CcSEcCtD
Tiagabine—Shock—Thalidomide—leprosy	0.00161	0.00233	CcSEcCtD
Tiagabine—Thrombocytopenia—Thalidomide—leprosy	0.0016	0.00231	CcSEcCtD
Tiagabine—Tachycardia—Thalidomide—leprosy	0.00159	0.00231	CcSEcCtD
Tiagabine—Hyperhidrosis—Thalidomide—leprosy	0.00158	0.00229	CcSEcCtD
Tiagabine—Anorexia—Thalidomide—leprosy	0.00156	0.00225	CcSEcCtD
Tiagabine—Hypotension—Thalidomide—leprosy	0.00153	0.00221	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Thalidomide—leprosy	0.00149	0.00215	CcSEcCtD
Tiagabine—Insomnia—Thalidomide—leprosy	0.00148	0.00214	CcSEcCtD
Tiagabine—Paraesthesia—Thalidomide—leprosy	0.00147	0.00212	CcSEcCtD
Tiagabine—Dyspnoea—Thalidomide—leprosy	0.00146	0.00211	CcSEcCtD
Tiagabine—Somnolence—Thalidomide—leprosy	0.00145	0.0021	CcSEcCtD
Tiagabine—Dyspepsia—Thalidomide—leprosy	0.00144	0.00208	CcSEcCtD
Tiagabine—Decreased appetite—Thalidomide—leprosy	0.00142	0.00206	CcSEcCtD
Tiagabine—Fatigue—Thalidomide—leprosy	0.00141	0.00204	CcSEcCtD
Tiagabine—Constipation—Thalidomide—leprosy	0.0014	0.00202	CcSEcCtD
Tiagabine—Pain—Thalidomide—leprosy	0.0014	0.00202	CcSEcCtD
Tiagabine—Feeling abnormal—Thalidomide—leprosy	0.00135	0.00195	CcSEcCtD
Tiagabine—Gastrointestinal pain—Thalidomide—leprosy	0.00134	0.00193	CcSEcCtD
Tiagabine—Urticaria—Thalidomide—leprosy	0.0013	0.00188	CcSEcCtD
Tiagabine—Abdominal pain—Thalidomide—leprosy	0.00129	0.00187	CcSEcCtD
Tiagabine—Body temperature increased—Thalidomide—leprosy	0.00129	0.00187	CcSEcCtD
Tiagabine—Hypersensitivity—Thalidomide—leprosy	0.0012	0.00174	CcSEcCtD
Tiagabine—Asthenia—Thalidomide—leprosy	0.00117	0.0017	CcSEcCtD
Tiagabine—Pruritus—Thalidomide—leprosy	0.00116	0.00167	CcSEcCtD
Tiagabine—Diarrhoea—Thalidomide—leprosy	0.00112	0.00162	CcSEcCtD
Tiagabine—Dizziness—Thalidomide—leprosy	0.00108	0.00156	CcSEcCtD
Tiagabine—Vomiting—Thalidomide—leprosy	0.00104	0.0015	CcSEcCtD
Tiagabine—Rash—Thalidomide—leprosy	0.00103	0.00149	CcSEcCtD
Tiagabine—Dermatitis—Thalidomide—leprosy	0.00103	0.00149	CcSEcCtD
Tiagabine—Headache—Thalidomide—leprosy	0.00102	0.00148	CcSEcCtD
Tiagabine—Nausea—Thalidomide—leprosy	0.00097	0.0014	CcSEcCtD
